Skip to main content
Premium Trial:

Request an Annual Quote

BioWisdom Joins $14.5M European Alzheimer Biomarker Project

NEW YORK, May 4 (GenomeWeb News) - Cambridge, UK-based BioWisdom said today that it will join the AddNeuroMed project of the European Commission's Innovative Medicines for Europe consortium, where it will use its Sofia software platform to help identify and validate Alzheimer's disease biomarkers.
 
BioWisdom said it will receive direct funding for its work, but it did not disclose financial details.
 
The INNOMED consortium of about 40 commercial and academic groups is led by the European Federation of Pharmaceutical Industries and Associations.
 
The consortium is sponsored by the EC under its Sixth Framework Program, which will provide about €11.5 million ($14.5 million) over three years, the statement added.

Filed under

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.